Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6012ce2ccf64fbc34ba201c9f11ada92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4fc9f91c7d8abfa6bb4be8d40fdf3ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_914ce1e64249e3dc0af1b375f3920f5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e1ffd6483ad3ef3fd96d5f0f4c9a973 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-235 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-075 |
filingDate |
2020-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1962624e090e71efa3900a9836ebd649 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2222b6c2dc7d69b0f817a5d32afbb62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9784ebe3121e4e83fc8c79bf102707f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddce8c084cbd4f7ea0a13da422311a05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4774e7a614a2396e962c76d9e1279c4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64b4f7e7b77318e954dba51346c7746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27fd0331b8a995e6609a7e6cc1c5c97 |
publicationDate |
2022-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2020358474-A1 |
titleOfInvention |
Adenovirus vectors and uses thereof |
abstract |
Provided herein are chimeric adenoviral vectors. The provided chimeric adenoviral vectors can be used to induce a protective immune response and/or express a transgene in a subject in need thereof. |
priorityDate |
2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |